(Q61873063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Vikas Gupta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

D Siegal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

W Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

R Sutherland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J Kuruvilla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

J H Lipton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

M Minden

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

H Messner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

31 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

51-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18372907%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2008.88

4 January 2020

exact match

0 references

cites work

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Marrow transplantation for severe aplastic anemia with significant renal impairment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Standardisation of multiplex fluorescent short tandem repeat analysis for chimerism testing.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021

Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.88

7 January 2021